Prognostic impact of FOXP3 expression in triple-negative breast cancer

Clinical relevance of TNM staging system according to breast cancer subtypes

(2011) Y. H. Park et al.   ANNALS OF ONCOLOGY

CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes

(2011) Fangfang Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers

(2011) D Tkocz et al.   ONCOGENE

Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy

(2010) Sylvain Ladoire et al.   BREAST CANCER RESEARCH AND TREATMENT

An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer

(2010) Sahar M. A. Mahmoud et al.   BREAST CANCER RESEARCH AND TREATMENT

Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

(2010) Eun Yoon Cho et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

CD4+CD25+CD127low/− regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression

(2009) Li-Song Shen et al.   CLINICAL IMMUNOLOGY

FOXP3 Expression and Overall Survival in Breast Cancer

(2009) Andrea Merlo et al.   JOURNAL OF CLINICAL ONCOLOGY

Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma

(2008) T Yoshioka et al.   BRITISH JOURNAL OF CANCER

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

(2008) Paul Salama et al.   JOURNAL OF CLINICAL ONCOLOGY

Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target

(2008) Sandra D Bohling et al.   MODERN PATHOLOGY

Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma

(2007) A. Sasaki et al.   EJSO